Evidence map›Paper›PMID 31271494›Full record

ArticleEMBO reports2019

U2AF

Manel Tari, Valérie Manceau, Jean de Matha Salone, Asaki Kobayashi, David Pastré, Alexandre Maucuer

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Targeting RNA splicing modulation: new perspectives for anticancer strategy?Journal of experimental & clinical cancer research : CR · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Manel TariSABNP, Univ Evry, INSERM U1204, Université Paris-Saclay, Evry, France.
Valérie ManceauInstitut Necker Enfants Malades (INEM), Inserm U1151 - CNRS UMR 8253, Université Paris Descartes, Paris, France.
Jean de Matha SaloneSABNP, Univ Evry, INSERM U1204, Université Paris-Saclay, Evry, France.
Asaki KobayashiSABNP, Univ Evry, INSERM U1204, Université Paris-Saclay, Evry, France.
David PastréSABNP, Univ Evry, INSERM U1204, Université Paris-Saclay, Evry, France.
Alexandre MaucuerSABNP, Univ Evry, INSERM U1204, Université Paris-Saclay, Evry, France.ORCID 0000-0003-2947-6654
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

ATIGEGenopoleInstitut National de la Santé et de la Recherche Médicale (Inserm)Université d'Evry
6 · The paper itself

Abstract

The essential splicing factor U2AF

Indexed as

Alternative SplicingCloning, MolecularComputational BiologyDNA, ComplementaryGene ExpressionGene Expression ProfilingGenetic VectorsHeLa CellsHumansNucleotide MotifsPhosphoproteinsRecombinant ProteinsRepressor ProteinsRibonucleoprotein, U2 Small NuclearRNA-Binding ProteinsRNA, Small InterferingDNA, ComplementaryHCC1 autoantigenPhosphoproteinspoly-U binding splicing factor 60KDaRBM17 protein, humanRecombinant ProteinsRepressor ProteinsRibonucleoprotein, U2 Small NuclearRNA-Binding ProteinsRNA, Small InterferingRNA Splicing FactorsSF3B1 protein, humanSplicing Factor U2AFU2AF2 protein, humanliquid-liquid phase separationRBM39SF3b1splicingU2AF2

Identifiers

PMID31271494
PMCPMC6681011
OpenAlexW2955860865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.